674 Deals: What a Thin Healthcare Buyer Pool Means for Practice Owners
For most of the past decade, an owner of a physician group, a dental practice, a home health agency, or an outsourced clinical services business could assume that a private equity platform would eventually call. New data from PitchBook says the calls are coming less often. Healthcare services deal count is tracking 26.5 percent below last year, and the projected annual total would be the lowest since 2017. That changes the math for any owner in the sector who was planning an exit around a buyer pool that has thinned.
What the numbers say
PitchBook's second-quarter healthcare services report, which drew fresh coverage this week, counts 337 private equity deals in the first half of 2026. Annualized, that is 674 transactions. The average from 2018 through 2024 was 903 a year. Second-quarter volume was down almost 19 percent from the same period in 2025, on top of a slow first quarter.
Deal value is weaker still. The first half produced $17.8 billion in disclosed transaction value against an annual average of $62.8 billion since 2018. Even doubling the first half leaves 2026 well short of a normal year. The single largest transaction in the quarter was not a buyout at all but KKR's $3.4 billion initial public offering of Global Medical Response, an exit rather than an entry.
The sharpest decline is in physician practice management, the segment where sponsors have been most active. Physician practice management companies, or PPMs, are the entities that own the non-clinical side of a medical group: billing, scheduling, staffing, real estate, and contracting. Deals in that segment peaked at 851 in 2021. There were 105 in the first half of this year. Quarter by quarter the trend has not turned: 102 deals in the fourth quarter of 2025, 89 in the first quarter of 2026, and 71 in the second. The segment is on track to fall 46 percent for the year.
Why buyers have stepped back
Three forces explain most of the drop, and they are not equally temporary.
The first is regulatory. At least 25 states have proposed or passed laws that add review requirements to healthcare transactions, restrict how non-physician entities can control medical practices, or both. California, Oregon, and Rhode Island each had new rules take effect this year. Seven states enacted laws in 2025. Bills were introduced this year in Hawaii, Indiana, New York, Pennsylvania, Vermont, and Virginia. PitchBook's lead healthcare analyst put the effect plainly: the review process is longer, and no sponsor wants to be the first one through a new one. Roll-up strategies that depend on closing a dozen small acquisitions a year are the ones most exposed, because each of those acquisitions may now carry its own filing and waiting period.
The second is utilization. Patient volumes through the first half of the year ran below expectations, and PitchBook points to the expiration of enhanced Affordable Care Act subsidies as a likely cause. Lower volumes hurt in two ways. They soften the earnings of the practices sponsors would buy, and they squeeze the hospitals and health systems that have historically been the largest strategic acquirers of physician practices. A hospital absorbing a hit to its own margins is not in a position to buy.
The third is the cost of debt. Higher rates and a more selective lending market have pushed sponsors toward fewer, larger deals across every sector, and healthcare is no exception. Small add-on acquisitions with thin margins are harder to finance and easier to skip.
State oversight is the most durable of the three. Utilization and financing move with the cycle. New review statutes do not get repealed when the cycle turns.
Where activity is still moving
The pullback is not uniform, and an owner should know which side of the line the business sits on.
Ancillary and outsourced services held up. Clinical staffing, diagnostic laboratories, and ambulatory care services all stayed active through the second quarter. These businesses sell to providers rather than practicing medicine themselves, which keeps most of them outside the corporate practice of medicine rules that the new state laws build on.
Within the provider segments, urgent and emergency care, elder care, and fertility were the bright spots. Ambulatory surgery centers remain in demand for a structural reason: the Centers for Medicare and Medicaid Services has continued to expand the list of procedures it will reimburse in an outpatient surgical setting, which keeps pushing volume toward lower-cost sites. A buyer underwriting an ASC is underwriting a tailwind, and that shows up in the multiple.
Multispecialty groups, dental service organizations, and single-specialty PPMs in states with active review regimes are on the other side of the line. Buyers have not disappeared for these businesses. They have become slower, more selective, and more inclined to structure consideration so the seller carries part of the regulatory and performance risk.
What a thinner buyer pool does to a seller
Fewer buyers means less competition for any given asset, and competition is what produces a premium. In a market where five platforms are chasing a well-run group, the owner sets the terms. In a market where one platform is looking and is in no hurry, the platform sets them.
The practical consequences show up in the structure rather than the headline number. Expect more of the price to move into earnouts, rollover equity, and deferred payments. Expect longer exclusivity periods, because a buyer that must clear a state review will not want to be outbid during the wait. Expect deeper diligence on payer mix and volume trends, because utilization is the variable buyers are most worried about right now.
None of this makes a sale a bad idea. It makes a sale in the next six months a negotiated outcome rather than an auction outcome, and an owner should price that difference before deciding when to go to market.
The case for preparing rather than waiting
PitchBook expects mean reversion, and its analysts note an early indicator worth watching: an increase in reorganization and cleanup engagements. Those are the projects a company undertakes when it intends to sell an underperforming asset and wants to fix it first. Sponsors do that work before a sale, not after they have given up on one. Advisors who serve the sector are seeing more of it.
For an owner, the implication is that the window will reopen, and the businesses that get the best outcome when it does will be the ones that used the trough to get ready. That means several concrete things.
Preparing a Healthcare Services Business for a Tighter Buyer Market
- Map the review requirements in every state where the business operates, and estimate how long a transaction would take to clear. A buyer will do this on day one; a seller who has already done it removes a reason to discount.
- Separate the clinical and non-clinical entities cleanly. Management services agreements, intercompany fees, and ownership structures that were informal in 2019 will be scrutinized under the new rules, and a messy structure costs time.
- Build a payer-mix and utilization bridge. Show what happened to volumes in the first half of 2026, why, and what the run rate looks like now. Buyers are underwriting this anyway.
- Commission a sell-side quality of earnings review. A quality of earnings analysis stress-tests reported profits to separate sustainable earnings from one-time items and owner adjustments. In a selective market, unverified add-backs are the first thing a buyer removes from the price.
- Identify which bright-spot category the business could credibly belong to. A multispecialty group with an ASC component, or a practice with a growing outsourced services line, has a different buyer conversation than one that does not.
- Talk to strategic buyers, not only sponsors. Hospitals are constrained now, but regional health systems, insurer-owned provider groups, and larger physician-led organizations do not face the same state-law posture that investor-backed platforms do.
The Bottom Line
Private equity's healthcare deal count is on track for its lowest year since 2017, with physician practice management activity down by roughly half and first-half deal value at less than a third of the annual norm. State oversight laws in at least 25 states are a structural cause and will outlast the cyclical ones. For an owner in the sector, a sale in the near term will be a negotiated outcome with more consideration deferred and more diligence on volumes. The better strategy for most is to use the trough to clean up entity structure, document utilization trends, and commission sell-side earnings verification, so that the business is first in line when buyers return. Ancillary and outsourced services, ambulatory surgery centers, urgent care, elder care, and fertility remain active categories today.